TY - JOUR
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Comorbidity
KW - Female
KW - Hospitalization
KW - Humans
KW - Male
KW - Opioid-Related Disorders/drug therapy/psychology
KW - Psychotherapy
KW - United States
KW - Medication for opioid use disorder
KW - Mental Health
KW - opioid use disorder
KW - Psychiatry
KW - Treatment discontinuation
AU - E. L. Friesen
AU - P. Kurdyak
A1 - 
AD - Institute of Health Policy Management & Evaluation, University of Toronto, Toronto, Canada; Faculty of Medicine, University of Toronto, Toronto, Canada; Centre for Addiction & Mental Health, Toronto, Canada. Electronic address: erik.friesen@mail.utoronto.ca.; Institute of Health Policy Management & Evaluation, University of Toronto, Toronto, Canada; Centre for Addiction & Mental Health, Toronto, Canada; ICES, Toronto, Canada. Electronic address: Paul.Kurdyak@camh.ca.
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use; Healthcare Disparities
CY - Ireland
DO - 10.1016/j.drugalcdep.2020.108244
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - . Published by Elsevier B.V
PP - Ireland
PY - 2020
SN - 1879-0046; 0376-8716
SP - 108244
T1 - The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder
T2 - Drug and alcohol dependence
TI - The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder
U1 - Opioids & Substance Use; Healthcare Disparities
U2 - 32861134
U3 - 10.1016/j.drugalcdep.2020.108244
VL - 216
VO - 1879-0046; 0376-8716
Y1 - 2020
Y2 - Nov 1
ER -